טוען...
Establishment of the World Health Organization 2(nd) International Standard for Factor XI, Plasma, Human
The 1(st) International Standard (IS) for blood coagulation factor XI (FXI), plasma, has been successfully used for potency labeling of FXI therapeutics and for diagnosis of FXI deficiency in patients. With stocks of the 1(st) IS near depletion, a replacement is required. In addition to the function...
שמור ב:
| הוצא לאור ב: | Front Med (Lausanne) |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Frontiers Media S.A.
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5357867/ https://ncbi.nlm.nih.gov/pubmed/28373973 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmed.2017.00028 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|